<p>Comparison of viable CD45<sup>+</sup> absolute count, viable CD34<sup>+</sup> absolute count (cells/µL), %viable CD34<sup>+</sup> within viable CD45<sup>+</sup> between the ADAMII-CD34 cell counter and flow cytometry in PBSC apheresis, and viable CD34<sup>+</sup> cell dose and estimated viable CD34<sup>+</sup> cell dose (×10<sup>6</sup> cells/kg) between the ADAMII-CD34 cell counter and the trypan blue exclusion method in cryopreserved stem cell product groups.</p>
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Comparison of viable CD45+ absolute count, viable CD34+ absolute count (cells/µL), %viable CD34+ within viable CD45+ between the ADAMII-CD34 cell counter and flow cytometry in PBSC apheresis, and viable CD34+ cell dose and estimated viable CD34+ cell dose (×106 cells/kg) between the ADAMII-CD34 cell counter and the trypan blue exclusion method in cryopreserved stem cell product groups.
创建时间：
2026-03-20
